NM_139076.3:c.1117G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_139076.3(ABRAXAS1):​c.1117G>A​(p.Asp373Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0504 in 1,614,020 control chromosomes in the GnomAD database, including 2,409 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D373G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.042 ( 192 hom., cov: 33)
Exomes 𝑓: 0.051 ( 2217 hom. )

Consequence

ABRAXAS1
NM_139076.3 missense

Scores

4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.30

Publications

25 publications found
Variant links:
Genes affected
ABRAXAS1 (HGNC:25829): (abraxas 1, BRCA1 A complex subunit) This gene encodes a protein that binds to the C-terminal repeats of breast cancer 1 (BRCA1) through a phospho-SXXF motif. The encoded protein recruits ubiquitin interaction motif containing 1 protein to BRCA1 protein and is required for DNA damage resistance, DNA repair, and cell cycle checkpoint control. Pseudogenes of this gene are found on chromosomes 3 and 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
MRPS18C (HGNC:16633): (mitochondrial ribosomal protein S18C) Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S18P family. The encoded protein is one of three that has significant sequence similarity to bacterial S18 proteins. The primary sequences of the three human mitochondrial S18 proteins are no more closely related to each other than they are to the prokaryotic S18 proteins. Pseudogenes corresponding to this gene are found on chromosomes 8p, 12p, 15q, and 22q. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0025427938).
BP6
Variant 4-83462582-C-T is Benign according to our data. Variant chr4-83462582-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416703.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0527 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139076.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABRAXAS1
NM_139076.3
MANE Select
c.1117G>Ap.Asp373Asn
missense
Exon 9 of 9NP_620775.2
ABRAXAS1
NM_001345962.2
c.790G>Ap.Asp264Asn
missense
Exon 8 of 8NP_001332891.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABRAXAS1
ENST00000321945.12
TSL:1 MANE Select
c.1117G>Ap.Asp373Asn
missense
Exon 9 of 9ENSP00000369857.3
ABRAXAS1
ENST00000506553.5
TSL:5
c.970G>Ap.Asp324Asn
missense
Exon 9 of 9ENSP00000426763.1
ABRAXAS1
ENST00000475656.6
TSL:2
n.*825G>A
non_coding_transcript_exon
Exon 8 of 8ENSP00000426080.1

Frequencies

GnomAD3 genomes
AF:
0.0419
AC:
6382
AN:
152136
Hom.:
192
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0104
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0456
Gnomad ASJ
AF:
0.0901
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0114
Gnomad FIN
AF:
0.0968
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0542
Gnomad OTH
AF:
0.0483
GnomAD2 exomes
AF:
0.0440
AC:
11060
AN:
251372
AF XY:
0.0446
show subpopulations
Gnomad AFR exome
AF:
0.00954
Gnomad AMR exome
AF:
0.0330
Gnomad ASJ exome
AF:
0.0836
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0893
Gnomad NFE exome
AF:
0.0556
Gnomad OTH exome
AF:
0.0587
GnomAD4 exome
AF:
0.0513
AC:
75042
AN:
1461766
Hom.:
2217
Cov.:
31
AF XY:
0.0506
AC XY:
36760
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.00833
AC:
279
AN:
33476
American (AMR)
AF:
0.0345
AC:
1541
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0896
AC:
2341
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39678
South Asian (SAS)
AF:
0.0110
AC:
946
AN:
86254
European-Finnish (FIN)
AF:
0.0839
AC:
4482
AN:
53416
Middle Eastern (MID)
AF:
0.0690
AC:
398
AN:
5766
European-Non Finnish (NFE)
AF:
0.0560
AC:
62283
AN:
1111936
Other (OTH)
AF:
0.0459
AC:
2771
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3909
7818
11727
15636
19545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2292
4584
6876
9168
11460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0419
AC:
6377
AN:
152254
Hom.:
192
Cov.:
33
AF XY:
0.0433
AC XY:
3220
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0104
AC:
432
AN:
41564
American (AMR)
AF:
0.0456
AC:
696
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0901
AC:
313
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.0114
AC:
55
AN:
4828
European-Finnish (FIN)
AF:
0.0968
AC:
1026
AN:
10594
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0542
AC:
3687
AN:
68020
Other (OTH)
AF:
0.0478
AC:
101
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
311
622
932
1243
1554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0516
Hom.:
689
Bravo
AF:
0.0387
TwinsUK
AF:
0.0485
AC:
180
ALSPAC
AF:
0.0509
AC:
196
ESP6500AA
AF:
0.0107
AC:
47
ESP6500EA
AF:
0.0536
AC:
461
ExAC
AF:
0.0424
AC:
5152
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.0629
EpiControl
AF:
0.0624

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Dec 15, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

ABRAXAS1-related disorder Benign:1
Nov 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Hereditary cancer-predisposing syndrome Benign:1
Aug 01, 2018
GeneKor MSA
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0040
T
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.80
T
MetaRNN
Benign
0.0025
T
MetaSVM
Benign
-1.0
T
PhyloP100
2.3
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.15
Sift
Benign
0.097
T
Sift4G
Benign
0.071
T
Polyphen
0.99
D
Vest4
0.12
MPC
0.40
ClinPred
0.0096
T
GERP RS
5.1
Varity_R
0.093
gMVP
0.15
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13125836; hg19: chr4-84383735; COSMIC: COSV55030274; API